Michael D. Schreiber to Cyclooxygenase Inhibitors
This is a "connection" page, showing publications Michael D. Schreiber has written about Cyclooxygenase Inhibitors.
Connection Strength
0.080
-
Increased indomethacin dosing for persistent patent ductus arteriosus in preterm infants: a multicenter, randomized, controlled trial. J Pediatr. 2008 Aug; 153(2):183-9.
Score: 0.080
Connection Strength
The connection strength for concepts is the sum of the scores for each matching publication.
Publication scores are based on many factors, including how long ago they were written and whether the person is a first or senior author.